Bank Of Montreal Intellia Therapeutics, Inc. Transaction History

Bank Of Montreal

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $2.08 Million - $2.87 Million	87,426 New	87,426 $2.41 Million
Q1 2023 Jun 13, 2024	SELL	$33.3 - $44.82 $2.65 Million - $3.57 Million	-79,712 Reduced 91.18%	7,714 $287,000
Q4 2022 Feb 01, 2023	BUY	$33.21 - $62.69 $214,005 - $403,974	6,444 New	6,444 $224,000
Q2 2022 Aug 11, 2022	SELL	$38.49 - $76.21 $2.11 Million - $4.17 Million	-54,728 Reduced 44.43%	68,437 $3.7 Million
Q1 2022 May 12, 2022	BUY	$58.27 - $118.99 $4.88 Million - $9.97 Million	83,804 Added 212.91%	123,165 $9.08 Million
Q4 2021 Feb 11, 2022	SELL	$100.76 - $138.36 $308,527 - $423,658	-3,062 Reduced 7.22%	39,361 $4.92 Million
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $5.32 Million - $7.11 Million	40,212 Added 1818.72%	42,423 $5.85 Million
Q2 2021 Aug 12, 2021	BUY	$60.88 - $161.91 $134,605 - $357,983	2,211 New	2,211 $336,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.